Hologic wins key Siemens patent fight as breast imaging market enters sharper phase
Find out how Hologic’s patent victory against Siemens Healthineers could reshape breast cancer detection technology and medtech competition.
Find out how Hologic’s patent victory against Siemens Healthineers could reshape breast cancer detection technology and medtech competition.
Preclinical IGRT is powerful but costly. KUBTEC Scientific’s XCELL TomoRad tests whether access, speed, and targeting can finally align.